(HelixDiff) ,α

Xuezhi Xie1,2, Pedro A Valiente1, Jisun Kim1

  • 1Donnelly Centre for Cellular and Biomolecular Research, University of Toronto, Toronto, Ontario M5S 3E1, Canada.

ACS central science
|May 27, 2024
PubMed
概括

新的人工智能模型HelixDiff可以生成精确的螺旋状蛋白质结构. 它成功设计了一种针对GLP-1受体的新型类药物,增强了稳定性和蛋白酶抵抗性.